🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This research study is studying Lenvatinib in combination with Pembrolizuma...
Status
Recruiting
Location
Yale University
Start Date
2025-07-18
Trial ID
NCT04645602
Treatments Being Tested
Substudy 02B is part of a larger research study where researchers are looki...
Status
Completed
Location
The Angeles Clinic and Research Institute ( Site 2009)
Start Date
2020-07-01
Trial ID
NCT04305054
Treatments Being Tested
This study is conducted to evaluate the efficacy, prognosis, adverse effect...
Status
Recruiting
Location
The Second Affiliated Hospital of Fujian Medical University
Start Date
2020-05-19
Trial ID
NCT05713994
Substudy 03A is part of a larger research study that is testing experimenta...
Status
Active Not Recruiting
Location
University of California at San Francisco ( Site 1008)
Start Date
2020-12-16
Trial ID
NCT04626479
Substudy 03B is part of a larger research study that is testing experimenta...
Status
Active Not Recruiting
Location
University of California at San Francisco ( Site 3008)
Start Date
2020-12-17
Trial ID
NCT04626518
Treatments Being Tested
This phase II trial studies how well lenvatinib and pembrolizumab work in t...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2021-11-04
Trial ID
NCT04171622
Treatments Being Tested
The goal of this study is to evaluate the efficacy and safety of pembrolizu...
Status
Active Not Recruiting
Location
The University of Alabama at Birmingham ( Site 0010)
Start Date
2021-04-14
Trial ID
NCT04736706
Treatments Being Tested
Combination treatment with antiangiogenic agents and anti-programmed cell d...
Status
Unknown
Location
Zhongshan Hospital, Fudan University
Start Date
2020-12-23
Trial ID
NCT04639284
Treatments Being Tested
This study consists of several parts: dose escalation, dose expansion, dose...
Status
Completed
Location
University of California at San Francisco ( Site 0004)
Start Date
2018-07-11
Trial ID
NCT03564691
Treatments Being Tested
This study will evaluate the efficacy and safety of pembrolizumab (MK-3475)...
Status
Completed
Location
Comprehensive Blood & Cancer Center [Bakersfield, CA] ( Site 1604)
Start Date
2019-06-26
Trial ID
NCT03976375
Treatments Being Tested